GlassScriptPhysician profile
William N Gasque
NPI 1740713668
$6,728.94
in general payments reported to CMS, 2019-2025
31 companies · $70.13 in 2025
The $70.13 reported for 2025 was less than what a typical Sports Medicine (Family Medicine) provider received nationally (typical 2025 total: $113).
See the full distribution for Sports Medicine (Family Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $11.80 · 2020: $15.29 · 2021: $5,050 · 2022: $1,249 · 2023: $219 · 2024: $113 · 2025: $70.13.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $402.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $402.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Peerless Surgical INC. | $3,058.15 | 2021 | |
| Arthrex, INC. | $1,515.00 | 2021 | |
| Abbvie INC. | $331.44 | 2021-2024 | |
| Novo Nordisk INC | $291.62 | 2020-2022 | |
| Pfizer INC. | $189.01 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $159.30 | 2021-2022 | |
| Amgen INC. | $133.05 | 2022 | |
| Dexcom, INC. | $113.69 | 2022-2023 | Dexcom G6 Transmitter |
| Sanofi-Aventis U.S. LLC | $96.69 | 2021-2023 | |
| Depuy Synthes Sales INC. | $74.21 | 2023-2025 | Monovisc, Orthovisc |
| Astrazeneca Pharmaceuticals LP | $71.38 | 2021-2022 | |
| Novartis Pharmaceuticals Corporation | $69.28 | 2022 | |
| Inari Medical, INC. | $69.25 | 2023 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Glaxosmithkline, LLC. | $64.67 | 2021-2023 | Shingrix |
| Esperion Therapeutics, INC. | $62.04 | 2021-2022 |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $60.39 | 2022 | |
| Merck Sharp & Dohme LLC | $39.51 | 2019-2021 | |
| Heraeus Medical, LLC. | $39.30 | 2025 | |
| Daiichi Sankyo INC. | $37.77 | 2022 | |
| Si-Bone, INC. | $33.58 | 2023-2024 | |
| Lilly USA, LLC | $26.26 | 2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $25.13 | 2022 | |
| Spr Therapeutics, INC | $23.51 | 2023 | Sprint Pns System |
| Bioventus LLC | $22.21 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $21.70 | 2022 | |
| Curonix LLC | $21.65 | 2024 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Medtronic, INC. | $18.43 | 2024 | Kyphon Express II Kyphopak Tray |
| Boehringer Ingelheim Pharmaceuticals, INC. | $16.57 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $16.27 | 2021 | |
| Heron Therapeutics, INC. | $16.09 | 2024 | Zynrelef |
| Abbott Laboratories | $11.79 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Gasque listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.